GPT and pneumonitis: The commonly reported adverse events (>10%) in the monotherapy group included pneumonitis and skin rash, whereas those in the combination therapy group included neutropenia, nausea, vomiting, increased alanine aminotransferase and aspartate aminotransferase levels, diarrhea, pneumonitis, and skin rash (Table 4).